Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs. 

Leave a Reply

Your email address will not be published. Required fields are marked *